These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31920677)

  • 1. Combined Use of Astragalus Polysaccharide and Berberine Attenuates Insulin Resistance in IR-HepG2 Cells
    Mao ZJ; Lin M; Zhang X; Qin LP
    Front Pharmacol; 2019; 10():1508. PubMed ID: 31920677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA-mRNA competing endogenous RNA network in IR-hepG2 cells ameliorated by APBBR decreasing ROS levels: a systematic analysis.
    Lin M; Mao ZJ
    PeerJ; 2020; 8():e8604. PubMed ID: 32140303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
    Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
    J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Ameliorates High-fat-induced Insulin Resistance in HepG2 Cells by Modulating PPARs Signaling Pathway.
    Zhang L; Yang C; Ding X; Zhang H; Luan Y; Tang Y; Liu Z
    Curr Comput Aided Drug Des; 2024 Oct; ():. PubMed ID: 39421985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.
    Xu J; Zhang Y; Yu Z; Guan Y; Lv Y; Zhang M; Zhang M; Chen L; Lv X; Guan F
    Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1464-1475. PubMed ID: 36269134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
    Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
    Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
    Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
    J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
    Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
    Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
    Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine improves insulin resistance in adipocyte models by regulating the methylation of hypoxia-inducible factor-3α.
    Wang Y; Gong W; Lv S; Qu H; He Y
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus polysaccharide ameliorates insulin resistance in HepG2 cells through activating the STAT5/IGF-1 pathway.
    Yue X; Hao W; Wang M; Fu Y
    Immun Inflamm Dis; 2023 Nov; 11(11):e1071. PubMed ID: 38018587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells.
    Li F; Zhao YB; Wang DK; Zou X; Fang K; Wang KF
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):64-69. PubMed ID: 26838742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats.
    Mi J; He W; Lv J; Zhuang K; Huang H; Quan S
    Diabetes Metab Syndr Obes; 2019; 12():1717-1725. PubMed ID: 31564939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine improves intralipid-induced insulin resistance in murine.
    Dong ZH; Lin HY; Chen FL; Che XQ; Bi WK; Shi SL; Wang J; Gao L; He Z; Zhao JJ
    Acta Pharmacol Sin; 2021 May; 42(5):735-743. PubMed ID: 32770172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
    Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
    Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
    Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway.
    Deng A; Wang Y; Huang K; Xie P; Mo P; Liu F; Chen J; Chen K; Wang Y; Xiao B
    BMC Complement Med Ther; 2023 Dec; 23(1):460. PubMed ID: 38102588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.